Journey Medical Corporation — Cash Flow (NASDAQ:DERM) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 2.18 M13.53 M5.24 M9.13 M 3.93 M Cash from investing activities 10 M20 M5 M15 M -94 K Cash from financing activities 53.02 M16.46 M4.8 M16.99 M 21.42 M Free cash flow -7.82 M-6.47 M240 K-5.87 M 3.93 M

新闻

B.Riley重申Journey Medical股票买入评级，维持12美元目标价

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

FDA为Fortress Biotech的门克斯病疗法设定新PDUFA日期

米诺环素研究显示使用16周后不会扰乱微生物群

Minocycline study shows no microbiome disruption after 16-week use

堡垒生物科技公司重新提交门克斯病治疗药物新药申请

Journey MedicalQ3每股收益及营收逊于预期

Journey Medical earnings missed by $0.06, revenue fell short of estimates

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates

Cisco, Flutter, Manulife and more set to report earnings Wednesday